Senior insider sale
Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$252.6K
6.95K shares
What this filing means
GHEUENS SARAH plans to sell 6.95K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $252.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001439222-26-000108
Officer· Chief Medical Officer
Since Sep 2021
6.95K
Shares to sell
$252.6K
Approx. market value
4.01K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of restricted stock units
Not applicable
7/1/2026
4.01KTotal acquired4.01K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Vesting of restricted stock units Not applicable | 4.01K | — |
| Total | 4.01K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.94K
Market value
$102.0K
4/2/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
4.01K
Market value
$150.5K
7/1/2026
Total
Units
6.95K
Value
$252.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/2/2026 | 2.94K | $102.0K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 4.01K | $150.5K | Nasdaq | Planned |
| Total | 6.95K | $252.6K | ||